Determining the structures of membrane proteins remains generally difficult even today. In fact, although more than 6,000 membrane proteins are encoded in the human genome, the number of human and mammalian membrane protein structures determined as of the end of 2024 is only about 250. Furthermore, structure determination by cryo-electron microscopy single-particle analysis generally faces issues such as preferred orientation and aggregation, and some researchers suggest that the probability of successfully determining a structure smoothly is less than 10%. Moreover, membrane proteins often require samples at concentrations of 1-5 mg/ml, which are higher than those needed for soluble proteins, due to problems such as adsorption to carbon support films. In addition, membrane proteins are often difficult to concentrate, so the success rate is likely even lower than for soluble proteins. On the other hand, cryo-LSEM is considered fully capable of collecting data from membrane protein samples at concentrations of around 0.02 mg/ml. Therefore, for low-concentration membrane protein samples that cannot be structurally determined by existing methods, this technique may be almost the only method currently offering the possibility of structure determination. In fact, to date, we have successfully concentrated a membrane protein sample at 0.03 mg/ml, which cannot be structurally determined by conventional methods, more than 90-fold on the grid and achieved a medium-resolution 3D reconstruction. We have also succeeded in obtaining a consistent density map of E. coli AcrB at 7 Å resolution using cryo-LSEM. Because consistent density maps have been obtained in both of the two cases tested so far, cryo-LSEM may simultaneously resolve issues such as aggregation and preferred orientation along with the concentration problem. Although there are no achievements yet in high-resolution structure determination, this is due to the limited number of examples and trials. We believe that as cryo-LSEM is applied to a broader range of membrane proteins, the success rate of high-resolution structure determination will also become clear. We sincerely commit to supporting the success of our technology license purchasers and will continue to aim to improve the success rate.